The Role of Aspirin and Unfractionated Heparin Combination Therapy Immediately After Total Hip and Knee Arthroplasty
Authors:
- Ali H. SobhASAli H. Sobh
- Denise M. KoueiterDKDenise M. Koueiter
- Anthony MellsAMAnthony Mells
- Matthew P. SiljanderMSMatthew P. Siljander
- Mark S. KaradshehMKMark S. Karadsheh
- 1 May 2018
- journal article
- research article
- Published by SLACK, Inc. in Orthopedics
- Vol. 41 (3) , 171-176
Abstract
Aspirin and unfractionated heparin (UH) are accepted options for venous thromboembolism (VTE) prophylaxis after total joint arthroplasty (TJA). The use of aspirin in addition to UH in preventing VTE after TJA has yet to be studied. The primary objective of this study was to determine VTE rates in patients receiving aspirin monotherapy and those receiving aspirin and UH combination therapy immediately following TJA. A TJA database from a single hospital system was retrospectively reviewed to identify all patients who underwent primary hip or knee arthroplasty from 2013 to 2016. Patients were divided into 3 groups based on postoperative VTE chemoprophylaxis: aspirin only, aspirin with 1 dose of UH, and aspirin with multiple doses of UH. There were 5350 patients included: 1024 aspirin only, 1695 aspirin plus 1 dose of UH, and 2631 aspirin plus multiple doses of UH. Deep venous thrombosis and pulmonary embolus rates did not vary significantly between groups (deep venous thrombosis: 1.1%, 0.9%, and 1.2%, respectively, P =.701; pulmonary embolus: 0.3%, 0.3%, and 0.2%, respectively, P =.894). Transfusion rates were significantly greater with 1 dose of UH (1.8%) and multiple doses of UH (4.3%) compared with aspirin only (0.9%) ( P <.001). Additionally, the postoperative hemoglobin decreased significantly more postoperatively with the use of UH ( P <.001). Aspirin and UH combination therapy did not decrease VTE incidence compared with aspirin monotherapy. Additionally, there was greater perioperative blood loss and an increased rate of blood transfusion in patients receiving UH. On the basis of these findings, the authors do not recommend UH as an additional mode of VTE prophylaxis when prescribing aspirin after elective TJA. [ Orthopedics . 2018; 41(3):171–176.]Keywords
This publication has 26 references indexed in Scilit:
- Prevention of Venous Thromboembolic Disease After Total Hip and Knee ArthroplastyJournal of Bone and Joint Surgery, 2013
- American Academy of Orthopaedic Surgeons Clinical Practice Guideline onJournal of Bone and Joint Surgery, 2012
- Prevention of VTE in Orthopedic Surgery PatientsChest, 2012
- Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous ThromboembolismJAMA, 2006
- Temporal Trends in Prevention of Venous Thromboembolism Following Primary Total Hip or Knee Arthroplasty 1996–2001Chest, 2003
- Prevention of Venous ThromboembolismChest, 2001
- Low-Molecular-Weight HeparinCirculation, 1998
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.BMJ, 1991
- Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 1983